EXPLORE OUR CLINICAL TRIALS AT ACC.19

Evolut Bicuspid Low-Risk Clinical Study
NOW ENROLLING

Evolut Low Risk Continued Access Study

Evolut™
TAVR Platform

DESTINATION THERAPY (DT) POST-APPROVAL STUDY (PAS) NOW ENROLLING IN THE UNITED STATES

To further confirm safety and effectiveness of the Medtronic HeartWare™ HVAD™ system when used as intended for DT in real-world clinical practice.

HeartWare™ HVAD™
System

APOGEE Trial:
NOW ENROLLING IN THE US

A post-approval on-label study to further enhance scientific understanding of the implant procedure, optimized blood pressure management, and anticoagulation/ antiplatelet therapy in patients receiving an HVAD for DT. Patients participating in DT PAS are eligible for co-enrollment in Apogee.

APOLLO TRIAL
NOW ENROLLING

Explore clinical trial options for patients with severe mitral regurgitation.

Intrepid™
Transcatheter Mitral Valve Replacement
(TMVR) System

CAUTION: Investigational device. Limited by federal law (USA) to investigational use. Exclusively for clinical investigation.

ONYX ONE
DAPT PROGRAM

Committed to advancing DAPT evidence in high-bleeding risk patients with Resolute Onyx™ DES.

Resolute Onyx™ DES
Zotarolimus-eluting Coronary Stent System

SPYRAL HTN CLINICAL PROGRAM
NOW ENROLLING

• USA
• Canada
• Europe
• Japan
• Australia

Symplicity Spyral™
Multi-electrode Renal Denervation Catheter

Caution: Investigational device. Limited by federal law (USA) to investigational use in the USA and Japan. Exclusively for clinical investigation.